Latest Pharmaceutical sciences Stories

MJ Freeway is pleased to announce that Congressman Jared Polis will discuss the status of his H.R. 499 legislation in a very special Educational Series Webinar sponsored by the NCIA on May 22 Denver, CO (PRWEB) May 17, 2013 MJ Freeway is pleased to announce the next in its Educational Series Webinars with very special guest speaker Congressman Jared Polis (D-CO). This educational Webinar is sponsored by the National Cannabis Industry Association. In February, 2013 Congressman Polis...

- IIMD China 2013 Hot Topics Preview SHANGHAI, May 17, 2013 /PRNewswire/ -- Medical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device (MD) trail evaluations are much more complicated than drug trails due to their unique clinical practices. Currently, the EMEA only evaluates MD safety instead of evaluating both safety and efficacy (which is left to the...

SAN DIEGO and CAMBRIDGE, Mass., May 17, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP announce that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint in the U.S. District Court for the District of Massachusetts. The complaint alleges that Aveo and certain of its officers violated the Securities Exchange Act of 1934 (the "Exchange Act") between January 3, 2012 and May 1, 2013 (the "Class Period"). (Logo:...

Committee to Review Respiratory Safety Data Comparing MOXDUO with Components SYDNEY and BEDMINSTER, N.J., May 17, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO( )New Drug Application (NDA). "The timing is within the expected date range of late June to late July," said Dr. John Holaday,...

FARMINGTON, Conn., May 17, 2013 /PRNewswire-iReach/ -- The escalation of new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Alternate delivery technologies are on the rise as a number of factors are converging to create both risk and opportunity for pharmaceutical makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward...

CANTON, Mass., May 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan, will present the Company's corporate overview on Monday, May 20, 2013 at 1:30pm EDT at the UBS Global Health Care Conference. The conference will be held at the Sheraton New York Hotel in New York City. The Company's lead development program is Oxycodone DETERx(®), an abuse-deterrent,...

"We have exactly what the states want" HOLLYWOOD, Calif., May 17, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced today that their CEO, Dr. Bruce Bedrick, was interviewed on Bloomberg Television's Street Smart. "Marijuana's market potential is massive," Adam Johnson, host of Street Smart stated. "The market for legalized pot could triple by...

CTS has become a reseller of the ReadyDock, Inc. line of tablet management products. The recently announced ReadyDock:UV™ provides chemical-free disinfection of tablet PCs and other mobile devices in 60 seconds, making mobility even more productive for healthcare and other industries. Austin, TX (PRWEB) May 16, 2013 Complete Tablet Solutions (CTS), a leading provider of mobility solutions to enhance productivity, is pleased to announce their partnership with ReadyDock, Inc. The...

http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today New York, NY (PRWEB) May 16, 2013 The prescription device safety center at DrugRisks.com is announcing updated information on the site for women using the IUD contraceptive Mirena. News from a federal judicial panel show the number of patients filing claims alleging injury from the devices is growing*. The goal of DrugRisks is to improve the...

FDA Regulation Confusing to Many and Hard to Predict Firm Helps New Companies Understand the FDA Process. Santa Clara, CA (PRWEB) May 16, 2013 New FDA consulting firm, The Tenzing Group, has launched an in-depth regulatory coaching service for Mobile Medical Application (MMA) startups to ensure success while understanding the costs and requirements of FDA regulation. “For unprepared startups, FDA regulations on mobile medical applications could result in a critical obstacle or worse...